Found: 8
Select item for more details and to access through your institution.
CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.618908
- By:
- Publication type:
- Article
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0803-9
- By:
- Publication type:
- Article
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination.
- Published in:
- Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 6b, p. 1532, doi. 10.1111/j.1582-4934.2009.00865.x
- By:
- Publication type:
- Article
Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, p. 1, doi. 10.1186/s13045-015-0218-1
- By:
- Publication type:
- Article
The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45721-z
- By:
- Publication type:
- Article
The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00147
- By:
- Publication type:
- Article